AzureBio is an innovative company founded in 2007 and focused on the development of medical devices in human health by incorporating discoveries in biomaterials into clinical practice.
AzureBio started as a drug formulation services company providing solutions in development of lyophilisates and liquid formulations of small molecules, peptides, proteins and vaccines.
Over the years AzureBio has grown to design and develop its own products for dental applications. Sil-Oss® is a new synthetic bone regeneration biomaterial that provides improved in vivo performance over other commonly used commercial bone regenerators.
With the goal of contributing to human health and providing quality services, the company incorporates experienced scientists and laboratory capabilities, and has established close collaborations with clinicians and prestigious research institutes.
Presently AzureBio is participated by venture capital funds and industrial partners.